Supportive Care in Cancer · Nov 10, 2026

Physiological prehabilitation for patients undergoing cellular therapy in multiple myeloma and lymphoma: a systematic review

By Barredo JMS, Lim CC, Loy Y et al.

Aims To evaluate physiological prehabilitation for adults with multiple myeloma or lymphoma undergoing cellular or immune-based therapies and to describe intervention characteristics and programme duration. Background Fatigue, physical deconditioning, and muscle weakness can compromise treatment readiness and quality of life (QoL). Evidence on exercise begun before these therapies remains limited. Methods Six databases were searched from inception to 4 September 2026. Randomised controlled trials (RCTs) and quasi-experimental studies were eligible if exercise began before stem cell transplantation, chimeric antigen receptor T-cell (CAR-T) therapy, or bispecific T-cell engager (BiTE) therapy and assessed physical function plus muscle strength, QoL, or fatigue. Joanna Briggs Institute tools informed methodological appraisal. Findings were synthesised narratively by outcome, alongside exercise characteristics and duration. Results Twelve studies (501 participants), comprising three pilot RCTs and nine quasi-experimental studies, were included. Ten evaluated transplantation and two CAR-T therapy; none evaluated BiTE therapy. Aerobic plus resistance or strength exercise predominated, and nine programmes reported a central or protocol duration within 4–8 weeks. Physical function and lower-limb performance findings were generally favourable; handgrip strength, QoL, and fatigue findings were mixed. Heterogeneous methods and predominantly uncontrolled designs limited interpretation. Conclusions Physiological prehabilitation shows preliminary promise for functional preparation before treatment. Aerobic and resistance exercise and the commonly reported programme durations warrant comparative evaluation. Implications Adequately powered, therapy-specific RCTs should standardise exercise reporting, assess clinically meaningful outcomes, and evaluate safety and sustained recovery after treatment.

doi.org/10.1007/s00520-026-11427-xPubMed 43007455Interventions

AgingResearch.News